News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–16
Matches
16
Sources here
7
Companies here
1
Search results Stored financial headlines

Active search

16 matching headlines

Ticker or company: SCNIMain company stories
Clear
Latest

citybiz Deals and strategy

Scinai Names Eran Kuratz to Lead CDMO Supply Chain and Business Processes

Scinai Immunotherapeutics Ltd. has appointed Eran Kuratz as the head of supply chain and business process administration for its Scinai Biopharma Services subsidiary. This strategic move aims to strengthen operational leadership and integrate the company's expanded contract development and manufacturing organization (CDMO) across its two sites in Israel following the acquisition of Recipharm Israel. Kuratz will oversee critical …

Main company 🇺🇸 United States
Read at citybiz
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
Stock Titan Deals and strategy Main company 🇺🇸 United States

Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration

Scinai Immunotherapeutics has appointed Eran Kuratz as Head of Supply Chain and Business Process Administration for its CDMO subsidiary, Scinai Biopharma Services. This appointment aims to strengthen operational infrastructure and support the integration and scaling of Scinai's expanded CDMO platform, which now includes two …

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Scinai Immunotherapeutics Ltd (SCNI) Stock News Today

This article provides an overview of Scinai Immunotherapeutics Ltd (SCNI) stock information from TradingKey. It shows the current stock price, recent performance, market capitalization, and various financial and analytical tools available on the platform. The news section indicates that more updates are expected soon.

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Earnings Main company 🇺🇸 United States

Scinai Immunotherapeutics Ltd (SCNI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Scinai Immunotherapeutics Ltd (SCNI), noting that no specific earnings forecast score is available for the company, contrasting with the Biotechnology & Medical Research industry average. It highlights the current stock price, market capitalization, and indicates that relevant …

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Scinai Immunotherapeutics Ltd (SCNI) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Scinai Immunotherapeutics Ltd (SCNI), noting its current valuation score of 7.40, ranking 176 out of 385 in its industry. It highlights the company's P/E ratio of -0.08, which is significantly below its recent high and above its …

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Scinai Immunotherapeutics Ltd (SCNI) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Scinai Immunotherapeutics Ltd (SCNI), noting its current score of 1.75 and ranking within the Biotechnology & Medical Research industry. It highlights the company's beta value of 2.09, indicating high volatility relative to the S&P 500 index. The …

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Scinai Immunotherapeutics Ltd

The article provides a revenue breakdown for Scinai Immunotherapeutics Ltd (SCNI), noting that relevant data for business segments and regional revenue and profit contribution have not yet been disclosed by the company. It briefly shows the current stock price, change, market cap, and indicates …

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

SCNI|Scinai Immunotherapeutics Ltd|Price:0.245|Chg%:-0.014

Scinai Immunotherapeutics Ltd (SCNI) is a biopharmaceutical company focused on developing medical products for autoimmune and infectious diseases, particularly NanoAbs for conditions like COVID-19 and psoriasis. Despite a recent stock price decline, the company shows strong fundamentals and significant growth potential, although analysts currently …

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Deals and strategy Main company 🇺🇸 United States

Scinai Immunotherapeutics Ltd (SCNI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Scinai Immunotherapeutics Ltd (SCNI). It notes that SCNI has distributed $0.00 in dividends over the past five years and details several merger-related stock splits with a 10:1 ratio that occurred in May 2024 and …

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Scinai Immunotherapeutics Ltd (SCNI) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Scinai Immunotherapeutics Ltd (SCNI), outlining its major shareholders and institutional holdings. It provides a breakdown of shareholder types, including corporations, individual investors, and various funds, along with a historical view of institutional shareholding and recent shareholder activity …

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Scinai Immunotherapeutics Ltd (SCNI) Institutional Confidence

This article provides an overview of institutional confidence in Scinai Immunotherapeutics Ltd (SCNI), including its stock price, market capitalization, and a table detailing institutional shareholdings and recent changes. The institutional confidence score remains stable at 3.00, reflecting how major investors are positioned in the …

SCNI main company
Sharemaestro market context Price below Trend Line 52 weeks -84.8% · Next-week setup negative 37.9% SCNI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context